Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEMAND study in Type 2 Diabetes
NCT00157586Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Feb 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of delapril, manidipine in type 2 diabetes mellitus (T2DM), hypertension (HTN), sponsored by Mario Negri Institute for Pharmacological Research. Started Feb 2002; status: completed.
02
Drugs
delaprilmanidipine
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on NCT00157586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157586.